These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21039639)

  • 41. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recoordination rather than resynchronization predicts reverse remodeling after cardiac resynchronization therapy.
    Wang CL; Wu CT; Yeh YH; Wu LS; Chang CJ; Ho WJ; Hsu LA; Luqman N; Kuo CT
    J Am Soc Echocardiogr; 2010 Jun; 23(6):611-20. PubMed ID: 20418055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiac resynchronization therapy for treatment of heart failure.
    Ho JK; Mahajan A
    Anesth Analg; 2010 Dec; 111(6):1353-61. PubMed ID: 21059745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac resynchronization therapy in left ventricular hypertrabeculation/non-compaction and myopathy.
    Stöllberger C; Blazek G; Bucher E; Finsterer J
    Europace; 2008 Jan; 10(1):59-62. PubMed ID: 18029382
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two-year performance of a preshaped lead for left ventricular stimulation.
    Schuchert A; Seidl K; Pfeiffer D; Oltmanns G; Dänschel W; Aydin MA; Paul V
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1610-4. PubMed ID: 15613123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
    Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
    Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship of baseline electrocardiographic characteristics with the response to cardiac resynchronization therapy for heart failure.
    Reynolds MR; Joventino LP; Josephson ME;
    Pacing Clin Electrophysiol; 2004 Nov; 27(11):1513-8. PubMed ID: 15546306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis.
    van Bommel RJ; Bax JJ; Abraham WT; Chung ES; Pires LA; Tavazzi L; Zimetbaum PJ; Gerritse B; Kristiansen N; Ghio S
    Eur Heart J; 2009 Oct; 30(20):2470-7. PubMed ID: 19717847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Invasive optimization of cardiac resynchronization therapy: role of sequential biventricular and left ventricular pacing.
    Kurzidim K; Reinke H; Sperzel J; Schneider HJ; Danilovic D; Siemon G; Neumann T; Hamm CW; Pitschner HF
    Pacing Clin Electrophysiol; 2005 Aug; 28(8):754-61. PubMed ID: 16105000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
    Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
    J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead.
    Sperzel J; Dänschel W; Gutleben KJ; Kranig W; Mortensen P; Connelly D; Trappe HJ; Seidl K; Duray G; Pieske B; Stockinger J; Boriani G; Jung W; Schilling R; Saberi L; Hallier B; Simon M; Rinaldi CA
    Europace; 2012 Mar; 14(3):365-72. PubMed ID: 21993431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Do the guidelines always show us the ideal treatment of patients for cardiac resynchronisation therapy?].
    Orski Z; Michałkiewicz D; Krzyżanowski K; Makowski K; Ryczek R
    Kardiol Pol; 2012; 70(9):968-70. PubMed ID: 22993015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quadripolar left ventricular lead implantation through the anchor struts of a mitral valve annuloplasty device.
    Shetty AK; Roy D; Thomas MR; Rinaldi CA
    Europace; 2011 Apr; 13(4):590-1. PubMed ID: 20974758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional and clinical implications of cardiac resynchronization therapy on outcomes of diabetic patients with heart failure.
    Santangelo G; Dugo D; Mulè M; Puzzangara E; Schillaci V; Timineri S; Capranzano P; Di Grazia A; Liotta C; Scandura S; Ragusa A; Tamburino C; Calvi V
    J Cardiovasc Med (Hagerstown); 2011 Jun; 12(6):396-400. PubMed ID: 21139508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minimally invasive thoracoscopic technique for cardiac resynchronization therapy.
    Droghetti A; Bottoli MC; Ragusa M; Pepi P; Giovanardi M; Reggiani A; Pozzetti D; Malacrida M; Colombo A; Muriana G
    Multimed Man Cardiothorac Surg; 2015; 2015():. PubMed ID: 26085492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How to upgrade a leadless pacemaker to cardiac resynchronization therapy.
    Lacour T; Bisson A; Bernard A; Fauchier L; Babuty D; Clementy N
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2578-2581. PubMed ID: 31512298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Late dislocation of the left ventricular lead as a cause of clinical and functional worsening during cardiac resynchronization therapy].
    Panchetti L; Piacenti M; Startari U; Rossi A; Morales MA
    Recenti Prog Med; 2011 Dec; 102(12):482-5. PubMed ID: 22258193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac resynchronization and atrial fibrillation: what's new?
    Barold SS; Herweg B
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1281-9. PubMed ID: 22564027
    [No Abstract]   [Full Text] [Related]  

  • 59. Cardiac resynchronization therapy using dual-site left ventricular pacing improves severe left ventricular dysfunction due to ischemic cardiomyopathy and permanent right ventricular apical pacing.
    Lotze U; Kirsch U; Oltmanns G; Schmidt H
    Int J Cardiol; 2012 Nov; 161(2):e26-8. PubMed ID: 22537977
    [No Abstract]   [Full Text] [Related]  

  • 60. Palpitations in a cardiac resynchronization therapy recipient: what's the mechanism?
    Badran H; Semmler V; Kolb C
    Pacing Clin Electrophysiol; 2012 Aug; 35(8):1018-20. PubMed ID: 22353038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.